Evaluating the effects of free movement on PET scan results
Impact of Free Mobility on FDG Uptake During a PET Scan: Randomized Controlled Non-inferiority Study
This study tests if letting patients move around after a special injection helps improve the quality of their PET scan images compared to those who have to stay still.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 284 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Centre Hospitalier Régional d'Orléans Academic / other |
| Locations | 1 site (Orléans) |
| Trial ID | NCT06799819 on ClinicalTrials.gov |
What this trial studies
This study investigates whether allowing patients to move freely after receiving an injection of 18F-Fluorodeoxyglucose (FDG) affects the quality of Positron Emission Tomography (PET) imaging. Participants will be randomly assigned to either a control group, which will rest after the injection, or an experimental group, which will be allowed to move freely. The study aims to determine if there is any significant difference in imaging quality, particularly regarding muscular uptake, and to assess the impact on patient comfort and stress levels during the procedure.
Who should consider this trial
Good fit: Ideal candidates are adults referred for FDG PET scans on an outpatient basis.
Not a fit: Patients who are bedridden or under legal protection will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance patient comfort during PET scans without compromising imaging quality.
How similar studies have performed: While some studies have explored muscular uptake in relation to physical activity, this specific approach of allowing free movement post-injection has not been previously evaluated.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Adults 2. Patient referred for FDG PET (excluding brain PET) and carried out on an outpatient basis. Exclusion Criteria: 1. Bedridden patients 2. Protected person (under guardianship or curatorship) 3. Persons under court protection 4. Persons deprived of liberty 5. Persons not affiliated to a social security scheme 6. Pregnant or breast-feeding woman
Where this trial is running
Orléans
- Centre Hospitalier Universitaire d'Orléans — Orléans, France (Recruiting)
Study contacts
- Principal investigator: Adeline FRAT — CHU Orléans
- Study coordinator: Adeline FRAT
- Email: adeline.frat@chu-orleans.fr
- Phone: 0238229722
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.